Monkey pox: Rethinking COVID‐19 to project future strategies against emerging and evolving pathogens
| dc.contributor.author | Lamptey, E. | |
| dc.contributor.author | Yaidoo, S. | |
| dc.contributor.author | Boakye, E.O. | |
| dc.contributor.author | et al. | |
| dc.date.accessioned | 2023-10-05T10:04:31Z | |
| dc.date.available | 2023-10-05T10:04:31Z | |
| dc.date.issued | 2022 | |
| dc.description | Research Article | en_US |
| dc.description.abstract | The COVID‐19 pandemic, which spread quickly across the globe toward the end of 2019 and throughout 2020 impacted almost every aspect of daily life [1]. It generated unprecedented uncertainty in the global economy,and disrupted daily routines. Individuals must navigate quarantines, school closing, job insecurity, significantly impairing the physical, mental, social, financial well‐ being of people [2–5]. The impact of the pandemic was more severe than global financial crisis, which was devastating as well to the health and welfare of the human population [6]. The World Health Organization (WHO) on January 30, 2020 announced that the SARS‐CoV‐2 crisis affected all humans globally with countless fatalities, destabilizing the economy order [7]. Preliminary estimates indicate that the total number of global “excess death” attributable to COVID‐19 in 2020 amount to at least 3 million or higher than official figures tracked by the WHO [8, 9]. | en_US |
| dc.identifier.other | DOI: 10.1002/hcs2.20 | |
| dc.identifier.uri | http://ugspace.ug.edu.gh:8080/handle/123456789/40274 | |
| dc.language.iso | en | en_US |
| dc.publisher | HEALTH CARE SCIENCE | en_US |
| dc.subject | Monkey pox | en_US |
| dc.subject | COVID‐19 | en_US |
| dc.subject | pathogens | en_US |
| dc.title | Monkey pox: Rethinking COVID‐19 to project future strategies against emerging and evolving pathogens | en_US |
| dc.type | Article | en_US |